Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

NKG2-C Antibody (L45): sc-80237

0.0(0)
Write a reviewAsk a question

Datasheets
  • NKG2-C Antibody (L45) is a mouse monoclonal IgG1 NKG2-C antibody provided at 100 µg/ml
  • raised against BaF/3 mouse peripheral blood cells transfected with NKG2-C and CD94 of human origin
  • recommended for detection of NKG2-C of human origin by FCM
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for NKG2-C Antibody (L45). This work is in progress.
    Crispr Promo Banner

    QUICK LINKS

    SEE ALSO...

    NKG2-C Antibody (L45) is a mouse monoclonal IgG1 antibody that detects NKG2-C protein of human origin by flow cytometry (FCM). Anti-NKG2-C antibody (L45) is available as a non-conjugated format. NKG2-C, also known as killer cell lectin-like receptor subfamily C member 2 (KLRC2), plays a crucial role in immune response by regulating natural killer (NK) cell activity. NKG2-C protein is primarily located on NK cell surfaces, where NKG2-C forms a heterodimer with CD94, facilitating recognition of class I major histocompatibility complex (MHC) molecules. NKG2-C and CD94 interaction is essential for proper receptor transport to cell surfaces, where these receptors non-covalently associate with DAP12, enhancing expression and functionality. Upon binding to HLA-E ligand, CD94/NKG2-C complex activates NK cell cytolytic activity, which is vital for immune system′s ability to target and eliminate infected or malignant cells. NKG2-C′s ability to modulate NK cell responses underscores importance in immune surveillance and potential therapeutic applications in cancer and infectious diseases.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

    Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

    LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

    NKG2-C Antibody (L45) References:

    1. Conservation and variation in human and common chimpanzee CD94 and NKG2 genes.  |  Shum, BP., et al. 2002. J Immunol. 168: 240-52. PMID: 11751968
    2. Variations of human killer cell lectin-like receptors: common occurrence of NKG2-C deletion in the general population.  |  Hikami, K., et al. 2003. Genes Immun. 4: 160-7. PMID: 12618865
    3. Role for NKG2-A and NKG2-C surface receptors in chronic CD4+ T-cell responses.  |  Ortega, C., et al. 2004. Immunol Cell Biol. 82: 587-95. PMID: 15550116
    4. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.  |  Gumá, M., et al. 2005. Eur J Immunol. 35: 2071-80. PMID: 15940674
    5. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C.  |  Houchins, JP., et al. 1997. J Immunol. 158: 3603-9. PMID: 9103421
    6. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.  |  Braud, VM., et al. 1998. Nature. 391: 795-9. PMID: 9486650
    7. Sequence analysis of a 62-kb region overlapping the human KLRC cluster of genes.  |  Plougastel, B. and Trowsdale, J. 1998. Genomics. 49: 193-9. PMID: 9598306
    8. Association of DAP12 with activating CD94/NKG2C NK cell receptors.  |  Lanier, LL., et al. 1998. Immunity. 8: 693-701. PMID: 9655483
    9. The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex.  |  Glienke, J., et al. 1998. Immunogenetics. 48: 163-73. PMID: 9683661

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    NKG2-C Antibody (L45)

    sc-80237
    100 µg/ml
    $322.00